VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma

Cancer Cell. 2012 Apr 17;21(4):532-46. doi: 10.1016/j.ccr.2012.02.019.

Abstract

The von Hippel-Lindau tumor-suppressor gene (VHL) is lost in most clear cell renal cell carcinomas (ccRCC). Here, using human ccRCC specimens, VHL-deficient cells, and xenograft models, we show that miR-204 is a VHL-regulated tumor suppressor acting by inhibiting macroautophagy, with MAP1LC3B (LC3B) as a direct and functional target. Of note, higher tumor grade of human ccRCC was correlated with a concomitant decrease in miR-204 and increase in LC3B levels, indicating that LC3B-mediated macroautophagy is necessary for RCC progression. VHL, in addition to inducing endogenous miR-204, triggered the expression of LC3C, an HIF-regulated LC3B paralog, that suppressed tumor growth. These data reveal a function of VHL as a tumor-suppressing regulator of autophagic programs.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Autophagy / genetics*
  • Carcinoma, Renal Cell / genetics*
  • Carcinoma, Renal Cell / pathology
  • Humans
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / pathology
  • Mice
  • MicroRNAs / genetics
  • MicroRNAs / physiology*
  • Microtubule-Associated Proteins / physiology*
  • Transplantation, Heterologous / pathology
  • Tumor Cells, Cultured
  • Von Hippel-Lindau Tumor Suppressor Protein / genetics*

Substances

  • MAP1LC3B protein, human
  • MIRN204 microRNA, human
  • MicroRNAs
  • Microtubule-Associated Proteins
  • Von Hippel-Lindau Tumor Suppressor Protein